Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs

Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases. 2020-09-17 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyPriority reviewfaster access to drugshealth care system needs. Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needsHTML https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/expanding-priority-review-pathways-for-drugs-meet-health-care-system-needs.html Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needsHTML https://www.canada.ca/fr/sante-canada/organisation/transparence/transparence-ouverture-en-matiere-reglementation/examens-reglementaire-materiel-medical/elargissement-processus-prioritaire-medicaments-repondant-aux-besoins-du-systeme-sante.html

This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases.

Data and Resources

Similar records